| Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders GC Leonardi, JF Gainor, M Altan, S Kravets, SE Dahlberg, L Gedmintas, ... Journal of Clinical Oncology, JCO. 2017.77. 0305, 2018 | 304 | 2018 |
| Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and very high PD-L1 expression EJ Aguilar, B Ricciuti, JF Gainor, KL Kehl, S Kravets, S Dahlberg, ... Annals of Oncology, 2019 | 269 | 2019 |
| Cytologic‐histologic correlation of programmed death‐ligand 1 immunohistochemistry in lung carcinomas E Russell‐Goldman, S Kravets, SE Dahlberg, LM Sholl, M Vivero Cancer cytopathology, 2018 | 93 | 2018 |
| Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis MM Awad, GC Leonardi, S Kravets, SE Dahlberg, A Drilon, SA Noonan, ... Lung Cancer, 2019 | 92 | 2019 |
| Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer B Ricciuti, S Kravets, SE Dahlberg, R Umeton, A Albayrak, SJ Subegdjo, ... Journal for ImmunoTherapy of Cancer 7 (1), 87, 2019 | 77 | 2019 |
| Impact of MET inhibitors on survival among patients (pts) with MET exon 14 mutant (METdel14) non-small cell lung cancer (NSCLC). MM Awad, GC Leonardi, S Kravets, SE Dahlberg, AE Drilon, S Noonan, ... Journal of Clinical Oncology 35 (15_suppl), 8511-8511, 2017 | 46 | 2017 |
| Imaging and artificial intelligence for progression of age-related macular degeneration K Romond, M Alam, S Kravets, L Sisternes, T Leng, JI Lim, D Rubin, ... Experimental Biology and Medicine, 15353702211031547, 2021 | 26 | 2021 |
| Success of genomic profiling of non–small cell lung cancer biopsies obtained by trans‐thoracic percutaneous needle biopsy RR Gill, DJ Murphy, S Kravets, LM Sholl, PA Janne, BE Johnson Journal of surgical oncology, 2018 | 15 | 2018 |
| Identification of a RAS-activating TMEM87A-RASGRF1 fusion in an exceptional responder to sunitinib with non-small cell lung cancer AJ Cooper, Y Kobayashi, D Kim, SE Clifford, S Kravets, SE Dahlberg, ... Clinical Cancer Research, 2020 | 12 | 2020 |
| Imaging Androgen Receptors in Breast Cancer with 18F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study H Jacene, J Hu, S Kravets, SC Cheng, A Abbott, SH Dubey, K McCall, ... Journal of Nuclear Medicine 60 (supplement 1), 595-595, 2019 | 12 | 2019 |
| MA04. 05 Outcomes in NSCLC Patients Treated with First-Line Pembrolizumab and a PD-L1 TPS of 50-74% vs 75-100% or 50-89% vs 90-100% EJ Alguilar, J Gainor, S Kravets, S Khosrowjerdi, C Lydon, A Adeni, ... Journal of Thoracic Oncology 13 (10), S367-S368, 2018 | 10 | 2018 |
| Comparison of outcomes with PD-L1 tumor proportion score (TPS) of 50-74% vs 75-100% in patients with non-small cell lung cancer (NSCLC) treated with first-line PD-1 inhibitors. E Jimenez Aguilar, H Rizvi, S Kravets, CA Lydon, AE Adeni, S Subegdjo, ... Journal of Clinical Oncology 36 (15_suppl), 9037-9037, 2018 | 9 | 2018 |
| Development and validation of a new MRI simulation technique that can reliably estimate optimal in vivo scanning parameters in a glioblastoma murine model A Protti, KL Jones, DM Bonal, L Qin, LS Politi, S Kravets, QD Nguyen, ... PloS one 13 (7), e0200611, 2018 | 6 | 2018 |
| Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib M Nishino, T Hida, S Kravets, SE Dahlberg, CA Lydon, H Hatabu, ... European Journal of Radiology Open 7, 100210, 2020 | 5 | 2020 |
| Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms S Karls, R Gold, S Kravets, Y Wang, SC Cheng, K Perez, J Chan, ... Annals of Nuclear Medicine, 1-12, 2021 | 3 | 2021 |
| Utility of FDG-PET/CT in Patients with Advanced Renal Cell Carcinoma with Osseous Metastases: Comparison with CT and 99mTc-MDP Bone Scan in a Prospective Clinical Trial EH Dibble, S Kravets, SC Cheng, C Sakellis, KP Gray, A Abbott, D Bossé, ... Kidney Cancer, 1-11, 0 | 3 | |
| Report on the PET/CT image-based radiation dosimetry of 18FDHT in women, an imaging agent with new applications for evaluation of androgen receptor status in patients with … K McCall, A Abbott, J Hu, SC Cheng, S Kravets, S Dubey, D Young, ... Journal of Nuclear Medicine 60 (supplement 1), 1630-1630, 2019 | 2 | 2019 |
| Evaluation of Optometrist’s Perspectives of Artificial Intelligence in Eye Care E Shorter, C Kinnaird, S Kravets, J Hallak, T Al-Khaled, E Cole, ... Investigative Ophthalmology & Visual Science 62 (8), 1727-1727, 2021 | 1 | 2021 |
| Association between Cognitive Function and Large Optic Nerve Cupping, Accounting for Cup-Disc-Ratio Genetic Risk Score S Kravets, RA Rupnow, A Sethi, M Espeland, PR Louis, S Rapp, B Klein, ... bioRxiv, 2021 | 1 | 2021 |
| Associations between Large Optic Nerve Cupping, Related Genetic Risk Scores and Cognitive function S Kravets, R Allozi, LR Pasquale, MA Espeland, SR Rapp, BEK Klein, ... Investigative Ophthalmology & Visual Science 62 (8), 1589-1589, 2021 | | 2021 |
